Charles River Laboratories International (CRL) Income from Continuing Operations (2009 - 2025)
Charles River Laboratories International (CRL) recorded quarterly Income from Continuing Operations of 276290000.0 in Q4 2025, down 597.32% quarter-over-quarter from 55556000.0 in Q3 2025, and down 29.26% on a YoY basis from 390572727.11 in Q4 2024.
Charles River Laboratories International (CRL) Income from Continuing Operations (2009 - 2025) Analysis & Trends
Charles River Laboratories International's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 276290000.0 for Q4 2025.
- In Q4 2025, Income from Continuing Operations fell 29.26% year-over-year to 276290000.0; the TTM figure through Dec 2025 stood at 142163000.0 (down 662.11% YoY), while the FY2025 annual figure was 142163000.0, down 662.11% from the prior year.
- Income from Continuing Operations was 276290000.0 for Q4 2025 at Charles River Laboratories International, down from 55556000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 189106000.0 in Q4 2022 to a low of 276290000.0 in Q4 2025.
- Historically, Income from Continuing Operations has averaged 62747150.0 across 5 years, with a median of 92088500.0 in 2021.
- The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations surged 48.94% in 2022, then plunged 213.12% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 139827000.0 in 2021, then surged by 35.24% to 189106000.0 in 2022, then decreased by 0.08% to 188952000.0 in 2023, then slumped by 213.12% to 213747000.0 in 2024, then decreased by 29.26% to 276290000.0 in 2025.
- The last three Income from Continuing Operations figures came in at 276290000.0 (Q4 2025), 55556000.0 (Q3 2025), and 52693000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 269.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -85.11 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Charles River Laboratories International | 9.26 Bn | 9.06 Bn | 744.94 Mn | -276.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -276.29 Mn |
| Sep 27, 2025 | 55.56 Mn |
| Jun 28, 2025 | 52.69 Mn |
| Mar 29, 2025 | 25.88 Mn |
| Dec 28, 2024 | -213.75 Mn |
| Sep 28, 2024 | 70.30 Mn |
| Jun 29, 2024 | 94.26 Mn |
| Mar 30, 2024 | 74.48 Mn |
| Dec 30, 2023 | 188.95 Mn |
| Sep 30, 2023 | 88.02 Mn |
| Jul 1, 2023 | 99.44 Mn |
| Apr 1, 2023 | 103.95 Mn |
| Dec 31, 2022 | 189.11 Mn |
| Sep 24, 2022 | 97.61 Mn |
| Jun 25, 2022 | 110.66 Mn |
| Mar 26, 2022 | 95.23 Mn |
| Dec 25, 2021 | 139.83 Mn |
| Sep 25, 2021 | 105.16 Mn |
| Jun 26, 2021 | 89.92 Mn |
| Mar 27, 2021 | 63.94 Mn |